Drug interactions
Glycopyrrolate inhaled + Ipratropium-salbutamol
Severity: Moderate
Glycopyrrolate inhaled and Ipratropium-salbutamol: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Inhaled glycopyrrolate and ipratropium are both inhaled antimuscarinic bronchodilators, and using them together duplicates therapy. This increases the risk of anticholinergic effects such as dry mouth, urinary retention and eye effects without clear added benefit.
What this interaction means in plain words
Glycopyrrolate inhaled and Ipratropium-salbutamol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Additive muscarinic receptor antagonism from two antimuscarinic agents.
What to do
Avoid routine concurrent use of two long- or short-acting antimuscarinics where possible; if combined, monitor for urinary retention, dry mouth and narrow-angle glaucoma symptoms.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Glycopyrrolate inhaled and Ipratropium-salbutamol, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Ipratropium-salbutamol
Frequently asked questions
Can I take Glycopyrrolate inhaled with Ipratropium-salbutamol?
MediHelp rates the interaction as moderate. Glycopyrrolate inhaled and Ipratropium-salbutamol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Inhaled glycopyrrolate and ipratropium are both inhaled antimuscarinic bronchodilators, and using them together duplicates therapy. This increases the risk of anticholinergic effects such as dry mouth, urinary retention and eye effects without clear added benefit.
How serious is the interaction between Glycopyrrolate inhaled and Ipratropium-salbutamol?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid routine concurrent use of two long- or short-acting antimuscarinics where possible; if combined, monitor for urinary retention, dry mouth and narrow-angle glaucoma symptoms.
What other medicines interact with Ipratropium-salbutamol?
MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
